Dr. Neil Bodie has 17 years of experience in biotechnology.
Past biotechnology experience: VP R&D Trinity Therapeutics Inc. Present biotechnology experience: CEO Paradigm Immunotherapeutics Inc.
Lead inventor of six issued US patents, including 8,815,813 Bodie (2014) “Methods for treating immune-mediated Dengue Fever infections and antibody-dependent enhancement of Dengue Fever infections, including Dengue Hemorrhagic Fever and Dengue Shock Syndrome”. Demonstrated in vitro and in vivo effectiveness in treating dengue. Zika is very closely related to dengue.
BS high honors in molecular genetics from UC Davis 1978. DVM UC Davis 1983. Four years post graduate experience in medical microbiology at UC Davis medical school.